WhiteSwell Medical
Acute Decompensated Heart Failure Treatment
StartupWhiteSwell Medical is a Shefayim-based startup in the Health Tech & Life Sciences sector, established in 2014. Acute Decompensated Heart Failure Treatment. The company has raised a total of $30M across 1 funding round, currently at the B stage. Key investors include RA Capital Management, InCube Ventures. The company has 11-50 employees.
With $30M in total funding, WhiteSwell Medical is a B-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: R&D. The company holds 1 patent.
- StageB
- ProductR&D
- ModelB2B
- Employees11-50
- HQShefayim
- DistrictCenter District
- Last Round$30M
- RA Capital Management
- InCube Ventures
5 articles covered by sources including www.businesswire.com,
www.medgadget.com,
www.siliconrepublic.com,
www.calcalistech.com.
What does WhiteSwell Medical do?
WhiteSwell Medical is a science-driven company dedicated to improving treatment of acute decompensated heart failure (ADHF), a primary cause of repeat hospitalization and emergency room visits. The company is developing a minimally invasive, catheter-based approach designed to more efficiently remove excess interstitial fluid in patients with ADHF by enhancing the natural fluid-removal process of the lymphatic system.
How much funding has WhiteSwell Medical raised?
WhiteSwell Medical has raised $30M in total funding across 1 rounds. The company is currently at the B stage. Key investors include RA Capital Management, InCube Ventures.
What sector is WhiteSwell Medical in?
WhiteSwell Medical operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is WhiteSwell Medical located?
WhiteSwell Medical is based in Shefayim, Israel, Center District. The company also has offices abroad.